Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0F7OX
|
|||
Former ID |
DNC010417
|
|||
Drug Name |
Benzaldehyde O-4-methoxyphenylcarbamoyl oxime
|
|||
Synonyms |
CHEMBL599469; benzaldehyde O-4-methoxyphenylcarbamoyl oxime; AC1NSB21; MLS001207590; MolPort-001-926-439; BDBM50309693; AKOS000588577; BAS 00346640; SMR000513623; ST50224746; AB00076721-01; [(E)-benzylideneamino] N-(4-methoxyphenyl)carbamate
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C15H14N2O3
|
|||
Canonical SMILES |
COC1=CC=C(C=C1)NC(=O)ON=CC2=CC=CC=C2
|
|||
InChI |
1S/C15H14N2O3/c1-19-14-9-7-13(8-10-14)17-15(18)20-16-11-12-5-3-2-4-6-12/h2-11H,1H3,(H,17,18)/b16-11+
|
|||
InChIKey |
TZKNCCSAQUKSHR-LFIBNONCSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
BioCyc | Anandamide degradation | |||
KEGG Pathway | Retrograde endocannabinoid signaling | |||
Panther Pathway | Anandamide degradation |
References | Top | |||
---|---|---|---|---|
REF 1 | Oxime carbamate--discovery of a series of novel FAAH inhibitors. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1272-7. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.